drugset / Trial / NCT06720285

The Efficacy of Regional Scalp Block in Craniotomy

NCT06720285

RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this clinical trial is to evaluate the role of scalp nerve block in craniotomy. The primary questions it seeks to answer are: What are the efficacy and safety profiles of scalp nerve block in craniotomy? The anesthesia protocol and monitoring were standardized for all participants. Participants were divided into two groups: the scalp nerve block group and the general anesthesia group. General anesthesia was induced using fentanyl (1-2 mcg/kg), propofol (1-2 mg/kg), and rocuronium (0.6 mg/kg). In the scalp nerve block group, a nerve block was administered using 0.5% ropivacaine.

Timeline

Start
2023-10-01
Primary completion
2023-11-30
Completion
2023-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 0.5 % Other
Background Fentanyl Other / unclassified 1 ug/kg
Background Fentanyl Other / unclassified 2 ug/kg
Background Propofol Small molecule 1 mg/kg
Background Propofol Small molecule 2 mg/kg
Background Rocuronium Other / unclassified 0.6 mg/kg

Indications

No indication recorded.